Harach H R, Williams E D
Service of Pathology, Dr A. Onativia Endocrinology and Metabolism Hospital, Salta, Argentina.
Clin Endocrinol (Oxf). 1995 Dec;43(6):701-6. doi: 10.1111/j.1365-2265.1995.tb00538.x.
The importance of iodine intake and thyroiditis in the pathogenesis of thyroid cancer remains controversial. We have investigated the natural history of thyroid cancer and thyroiditis in a goitrous region before and after iodine prophylaxis over a 31-year period.
For the analysis of thyroid cancer the material was divided in two periods. The first 15 years (59 cases), including 5 years before prophylaxis, was compared with the second 16 years (85 cases), a period well after iodine supplementation of salt. Histological diagnosis of the tumours was based on the WHO system. Moderate to severe thyroiditis in the non-tumoral surrounding thyroid from female patients was recorded. For this, the material was analysed in the two periods in relation to the introduction of iodine prophylaxis in 1963, taking account of the age of the patients.
Papillary carcinomas formed the largest group of tumours in both periods, with nearly twice as many in the second period as the first, while the numbers of follicular and medullary carcinomas remained about the same. The ratio of papillary to follicular carcinoma rose from 1.7:1 in the first period to 3.1:1 in the second. All three thyroid lymphomas were of the non-Hodgkin's type, and all occurred in the second period in females aged over 50. A severe lymphoid thyroiditis was present in the two cases with assessable background thyroid tissue. The frequency of lymphoid infiltrate in females rose from 8% (1/12) before 1963 to 25% (18/72) after prophylaxis in the whole series. After salt prophylaxis, thyroiditis was more frequent in patients with papillary carcinoma in general (31%), and clinically significant papillary carcinomas in particular (35%), than in those with non-papillary tumours (6%) (chi 2, P < 0.05 and P < 0.025, respectively).
Our observations indicate that a high dietary intake of iodine may be associated with a high frequency of papillary carcinoma and thyroiditis, and that thyroiditis is more commonly associated with papillary carcinoma than with other thyroid tumours. The occurrence of non-Hodgkin's lymphomas only in the post-prophylaxis period may be linked to an increase in thyroiditis.
碘摄入和甲状腺炎在甲状腺癌发病机制中的重要性仍存在争议。我们调查了在一个甲状腺肿流行地区,在长达31年的碘预防前后甲状腺癌和甲状腺炎的自然病程。
为分析甲状腺癌,将资料分为两个时期。将前15年(59例),包括预防前5年,与后16年(85例)进行比较,后一时期是在食盐加碘很久之后。肿瘤的组织学诊断依据世界卫生组织系统。记录女性患者非肿瘤性周围甲状腺组织中的中重度甲状腺炎。为此,考虑患者年龄,将资料按1963年引入碘预防措施分为两个时期进行分析。
两个时期乳头状癌都是最大的肿瘤类型组,第二时期的数量几乎是第一时期的两倍,而滤泡状癌和髓样癌的数量保持大致相同。乳头状癌与滤泡状癌的比例从第一时期的1.7:1升至第二时期的3.1:1。所有3例甲状腺淋巴瘤均为非霍奇金淋巴瘤,且均发生在第二时期50岁以上的女性。在2例有可评估背景甲状腺组织的病例中存在严重的淋巴细胞性甲状腺炎。在整个系列中,女性淋巴细胞浸润的频率从1963年前的8%(1/12)升至预防后的25%(18/72)。食盐预防后,一般乳头状癌患者中甲状腺炎更常见(31%),特别是临床显著的乳头状癌患者中(35%),而非乳头状肿瘤患者中为6%(卡方检验,P分别<0.05和P<0.025)。
我们的观察表明,高碘饮食摄入可能与乳头状癌和甲状腺炎的高发生率相关,且甲状腺炎与乳头状癌的关联比与其他甲状腺肿瘤更常见。非霍奇金淋巴瘤仅在预防后时期出现可能与甲状腺炎增加有关。